1. Home
  2. SXTC vs AWH Comparison

SXTC vs AWH Comparison

Compare SXTC & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXTC
    SELLHOLDBUYas of 15 hours ago
  • AWH
    SELLHOLDBUYas of 15 hours ago
  • Stock Information
  • Founded
  • SXTC 2005
  • AWH 1993
  • Country
  • SXTC China
  • AWH United States
  • Employees
  • SXTC N/A
  • AWH N/A
  • Industry
  • SXTC Biotechnology: Pharmaceutical Preparations
  • AWH Medical/Dental Instruments
  • Sector
  • SXTC Health Care
  • AWH Health Care
  • Exchange
  • SXTC Nasdaq
  • AWH Nasdaq
  • Market Cap
  • SXTC N/A
  • AWH 1.6M
  • IPO Year
  • SXTC 2019
  • AWH N/A
  • Fundamental
  • Price
  • SXTC $2.57
  • AWH $0.11
  • Analyst Decision
  • SXTC
  • AWH Buy
  • Analyst Count
  • SXTC 0
  • AWH 2
  • Target Price
  • SXTC N/A
  • AWH $4.40
  • AVG Volume (30 Days)
  • SXTC 1.6M
  • AWH 13.0M
  • Earning Date
  • SXTC 01-01-0001
  • AWH 03-27-2025
  • Dividend Yield
  • SXTC N/A
  • AWH N/A
  • EPS Growth
  • SXTC N/A
  • AWH N/A
  • EPS
  • SXTC N/A
  • AWH N/A
  • Revenue
  • SXTC $1,928,497.00
  • AWH $9,182,000.00
  • Revenue This Year
  • SXTC N/A
  • AWH $11.87
  • Revenue Next Year
  • SXTC N/A
  • AWH $79.10
  • P/E Ratio
  • SXTC N/A
  • AWH N/A
  • Revenue Growth
  • SXTC N/A
  • AWH 0.31
  • 52 Week Low
  • SXTC $2.40
  • AWH $0.08
  • 52 Week High
  • SXTC $26.96
  • AWH $3.63
  • Technical
  • Relative Strength Index (RSI)
  • SXTC 48.21
  • AWH 33.87
  • Support Level
  • SXTC $2.66
  • AWH $0.12
  • Resistance Level
  • SXTC $3.09
  • AWH $0.36
  • Average True Range (ATR)
  • SXTC 0.22
  • AWH 0.01
  • MACD
  • SXTC -0.13
  • AWH 0.01
  • Stochastic Oscillator
  • SXTC 23.53
  • AWH 37.14

Stock Price Comparison Chart: SXTC vs AWH

SXTC
AWH
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100110120SXTC VS AWH

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use